Hematologic Malignancies With RUNX1::ZFPM2 Translocation: A Case Report and Literature Review.
文献摘要
RUNX1 rearrangements are recurrent in myeloid neoplasms, but rare fusion partners remain poorly characterized. We report the first acute myeloid leukemia (AML) with a RUNX1::ZFPM2 fusion generated by t(8;21)(q23;q22). A 72-year-old woman presented with acute myelomonocytic leukemia carrying concomitant IDH2 and NRAS mutations. Azacitidine-venetoclax induced transient remission with a marked decrease in the fusion transcript. However, persistent cytopenias, molecular relapse, and treatment resistance led to death 1 year after diagnosis. This case expands the spectrum of RUNX1 -rearranged AML and suggests a biological behavior distinct from classical RUNX1::RUNX1T1 -positive AML. Trial registration The authors have confirmed clinical trial registration is not needed for this submission.